Allergy Learning: Early Review/Testing & Efficient Diagnosis (ALERTED)

“过敏诊断的根本性变化的迫切需要说明：1。过敏症患者数量快速增长，例如，英国儿童食物过敏的发病率在10年内翻了一番，44%的英国成年人现在患有过敏症（_Mintel，2010）_2。过敏测试等待时间过长（通常超过2年）3.据估计，欧盟每年因未经治疗的过敏症而产生的间接可避免成本在510亿欧元至1550亿欧元之间。（欧洲过敏和临床免疫学学会，2016）（过敏学习：早期审查/测试和高效诊断“）将开发新型集成模块化技术来应对这些挑战，目标是低成本、高效、可靠的过敏诊断，赋予患者和临床医生权力，减少等待时间和每个病人的费用，同时提供潜在的长期流行病学信息。该项目力求将联合收割机新技术与方法和治疗的逐步改变相结合。预计过敏的早期诊断允许及时治疗将避免可避免的危机，并大大改善患者的体验和结果。"

"An urgent need for radical change in allergy diagnostics is illustrated by:1. Rapid growth in number of allergy sufferers e.g. incidence of food allergy in UK children doubled in 10 years, 44% of UK adults now have an allergy (_Mintel, 2010)_2. Lengthening waiting times for allergy testing (commonly over 2 years)3. The EU's annual indirect avoidable cost of untreated allergies is estimated at between €51bn and €155bn (The European Academy of Allergy and Clinical Immunology, 2016)The ALERTED Primer study ('Allergy Learning: Early Review/Testing & Efficient Diagnosis') will develop novel integrated modular technology to address these challenges, targeting low-cost, efficient, reliable, allergy diagnostics, empowering patients and clinicians, reducing waiting times and cost per patient, while providing potentially long-term epidemiological information.The project seeks to combine new technology with a step-change in methodology and treatment. It is anticipated that early diagnosis of allergies allowing for prompt treatment will avert avoidable crises and substantially improve patient experience and outcomes."